List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 118 studies with search of: malignant glioma | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Panitumumab and Irinotecan for Malignant Gliomas
Condition: Recurrent Grade IV Malignant Glioma
Intervention: Drug: Panitumumab in Combination with Irinotecan
2 Recruiting Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients
Condition: Malignant Glioma
Intervention: Biological: Dendritic cell Vaccine
3 Recruiting A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Condition: Malignant Glioma
Interventions: Drug: Armodafinil;   Other: Placebo
4 Recruiting Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy
Condition: Malignant Glioma
Intervention: Procedure: 3T MRI Scanning
5 Recruiting Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas
Condition: Malignant Glioma
Intervention: Biological: Dendritic vaccine pulsed with multiple peptides
6 Recruiting Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas
Condition: Malignant Glioma
Intervention: Biological: REOLYSIN®
7 Recruiting Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: AdV-tk;   Drug: Valacyclovir
8 Recruiting Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Conditions: Brain Cancer;   Malignant Glioma
Intervention: Other: radiotherapy (RT) in combination with temozolomide and bevacizumab
9 Recruiting Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma
Intervention: Drug: Vandetanib and Etoposide
10 Not yet recruiting Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Condition: Recurrent Malignant Glioma
Intervention: Drug: IL13-PE38QQR
11 Recruiting Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: AdV-tk;   Drug: Valacyclovir
12 Not yet recruiting Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)
Condition: Malignant Glioma
Intervention: Drug: bevacizumab and CPT-11 and Carboplatin
13 Recruiting Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme
Condition: Malignant Glioma
Intervention: Drug: NPC-08
14 Not yet recruiting Radiosurgery and Avastin for Recurrent Malignant Gliomas
Condition: Malignant Glioma
Interventions: Radiation: Radiosurgery;   Drug: Bevacizumab
15 Recruiting Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
Condition: Glioblastoma
Intervention: Drug: bsi-201 plus temozolomide
16 Recruiting A Study of XL765 in Combination With Temozolomide in Adults With Malignant Gliomas
Conditions: Mixed Gliomas;   Malignant Gliomas;   Glioblastoma Multiforme
Interventions: Drug: XL765;   Drug: Temozolomide
17 Recruiting A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
Interventions: Other: Taking EIAEDs (enzyme-inducing anticonvulsant medications);   Other: NOT taking EIAEDs
18 Recruiting Ph I Trial of Oral Topotecan + Temozolomide in Treatment of Pts w Malignant Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: Temodar and Topotecan
19 Recruiting Sunitinib to Treat Recurrent Brain Cancer
Conditions: Glioblastoma Multiforme;   Malignant Gliomas;   Anaplastic Gliomas
Intervention: Drug: Sutent (sunitinib)
20 Recruiting Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors
Condition: Recurrent Malignant Gliomas
Intervention: Drug: Panobinostat

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services